EFFECTS OF AN AMLODIPINE (AML)- AND OLMESARTAN MEDOXOMIL (OM)-BASED TITRATE-TO-GOAL REGIMEN IN BLACK OR NON-BLACK PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES

EFFECTS OF AN AMLODIPINE (AML)- AND OLMESARTAN MEDOXOMIL (OM)-BASED TITRATE-TO-GOAL REGIMEN IN BLACK OR NON-BLACK PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES

A prespecified subgroup analysis of an open-label study evaluating an AML/OM-based regimen in Blacks and Non-Blacks with type 2 diabetes and hypertension is reported. Drug-related treatment-emergent adverse events (DR-TEAEs) were experienced by 20.0% and 19.2% of Blacks and Non-Blacks, respectively....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ethnicity & disease 2010-09, Vol.20 (4), p.np-np
Hauptverfasser: Ram, C V S, Neutel, J M, Shojaee, A, Stoakes, K A, Qian, C
Format: Artikel
Sprache:eng
Schlagworte:
African Americans
Comparative studies
Diabetes
Drug therapy
Effectiveness
Health and Medicine
Hypertension
Medical research
Side Effects
Statistical Data
United States
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A prespecified subgroup analysis of an open-label study evaluating an AML/OM-based regimen in Blacks and Non-Blacks with type 2 diabetes and hypertension is reported. Drug-related treatment-emergent adverse events (DR-TEAEs) were experienced by 20.0% and 19.2% of Blacks and Non-Blacks, respectively. AML/OM plus hydrochlorothiazide enabled significant BP reductions and BP target achievements, and was well-tolerated.
ISSN:1049-510X